ACIU AC Immune SA Loading...

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
12:00
Apr 29 ◎
Alicia Alimo President of North America, Biogen Inc. BIIB Q1 FY26 call
A pilot program with AC Immune is testing blood-based biomarkers in primary care settings for Alzheimer's, potentially expanding the diagnostic and treatment funnel.
ACIU
HIGH
07:12
Apr 01
moodywriter13
Leading developer trades at negative EV
Author highlights the company as a leading precision medicine developer with major strategic partnerships, noting it currently trades at an attractive negative enterprise value.
ACIU
MED

About ACIU Analyst Coverage

Buzzberg tracks ACIU (AC Immune SA) across 2 sources. 0 bullish vs 0 bearish calls from 2 analysts. Sentiment: evenly split. 2 total trade ideas tracked. Latest voices: Alicia Alimo, moodywriter13.